S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TSHA Taysha Gene Therapies Inc

2.44

-0.01 (-0.41%)

Last Updated: 05:35:56

Delayed by 15 minutes

Taysha Gene acquires rights to AAV9 gene therapy program for severe neurodegenerative disease

To read the full story on Seeking Alpha, click here.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Mar 2024 to May 2024

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies Inc News

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 5 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Another Biotech Steals The Show Following Major Clinical Data Release
Thursday 21 March 2024 (1 month ago) • AllPennyStocks.com

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.

US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat
Tuesday 19 March 2024 (1 month ago) • IH Market News

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 2 March 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs
Friday 16 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Saturday 10 February 2024 (3 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 3 February 2024 (3 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference
Tuesday 23 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 11 January 2024 (4 months ago) • Edgar (US Regulatory)

More Taysha Gene Therapies Inc News Articles

Invesco QQQ Trust Series 1

JP Morgan Chase

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions